Evidence map›Paper›PMID 33082803›Full record

ArticleIranian journal of parasitology

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB

Yasaman Taslimi, Farnaz Zahedifard, Tahereh Taheri, Delaram Doroud, Sakineh Latif Dizaji, Noushin Saljoughian, Sima Rafati

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yasaman TaslimiDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Tehran, Tehran, Iran.
Farnaz ZahedifardDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Tehran, Tehran, Iran.
Tahereh TaheriDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Tehran, Tehran, Iran.
Delaram DoroudQuality Control Department, Production and Research Complex, Pasteur Institute of Tehran, Tehran, Iran.
Sakineh Latif DizajiDepartment of Laboratory Animal Science, Pasteur Institute of Tehran, Tehran, Iran.
Noushin SaljoughianDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Tehran, Tehran, Iran.
Sima RafatiDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Tehran, Tehran, Iran.
Pasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVisceral leishmaniasis is the most severe form of leishmaniasis caused by

methodsWe evaluated the effectiveness of these DNA and live vaccination harboring A2-CPA-CPB

resultsBoth immunization strategies partially protect hamsters against

conclusionBoth test groups (DNA/DNA and Live/Live) elicited high levels of IgG2 and total IgG as humoral immune responses and lower level of parasite propagation in both liver and spleen.

Indexed as

DNA vaccinationHamster immunizationLive vaccinationVisceral leishmaniasis

Identifiers

PMID33082803
PMCPMC7548471
OpenAlexW3094017060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.